PDGF, pericytes and the pathogenesis of idiopathic basal ganglia calcification (IBGC)

Brain Pathology

Volumn 24, Issue 4, 2014, Pages 387-395

  Betsholtz, Christer ^a   Keller, Annika ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Pericytes

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR;

BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; CARCINOGENESIS; CONFERENCE PAPER; CYTOPLASM; FAHR DISEASE; GENETICS; HUMAN; NONHUMAN; OBSERVATION; OSTEOBLAST; PATHOGENESIS; PATHOPHYSIOLOGY; PERICYTE; ANIMAL; CALCINOSIS; DEGENERATIVE DISEASE; EXTRAPYRAMIDAL SYNDROME; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BASAL GANGLIA DISEASES; BLOOD-BRAIN BARRIER; CALCINOSIS; HUMANS; NEURODEGENERATIVE DISEASES; PERICYTES; PLATELET-DERIVED GROWTH FACTOR;

EID: 84902661616     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12158     Document Type: Conference Paper

References (95)

1. Abramsson A, Kurup S, Busse M, Yamada S, Lindblom P, Schallmeiner E, et al. (2007) Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development. Genes Dev 21: 316-331.
2. Abramsson A, Lindblom P, Betsholtz C, (2003) Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 112: 1142-1151.
3. Andrae J, Gallini R, Betsholtz C, (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22: 1276-1312.
4. Armulik A, Abramsson A, Betsholtz C, (2005) Endothelial/pericyte interactions. Circ Res 97: 512-523.
5. Armulik A, Genové G, Betsholtz C, (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21: 193-215.
6. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, et al. (2010) Pericytes regulate the blood-brain barrier. Nature 468: 557-561.
7. Armulik A, Genove G, Betsholtz C, (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21: 193-215.
8. Baker M, Strongosky A, Sanchez-Contreras M, Yang S, Ferguson W, Calne D, et al. (2014) SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia. Neurogenetics 15: 23-30.
9. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, et al. (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68: 409-427.
10. Bjarnegård M, Enge M, Norlin J, Gustafsdottir S, Fredriksson S, Abramsson A, et al. (2004) Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 131: 1847-1857.
11. Chakrabarty P, Ceballos-Diaz C, Lin W-L, Beccard A, Jansen-West K, McFarland N, et al. (2011) Interferon-γ induces progressive nigrostriatal degeneration and basal ganglia calcification. Nat Neurosci 14: 694-696.
12. Chen W-J, Yao X-P, Zhang Q-J, Ni W, He J, Li H-F, et al. (2013) Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification. Gene 529: 159-162.
13. Cheung YH, Gayden T, Campeau PM, LeDuc CA, Russo D, Nguyen VH, et al. (2013) A recurrent PDGFRB mutation causes familial infantile myofibromatosis. Am J Hum Genet 92: 996-1000.
14. Crow Y, Hayward B, Parmar R, Robins P, Leitch A, Ali M, et al. (2006) Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet 38: 917-920.
15. Daneman R, Zhou L, Kebede AA, Barres BA, (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468: 562-566.
16. Delacour A, (1850) Ossification des capillaires du cerveau. Ann Med Psychol 2: 458-461.
17. Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA, et al. (1983) Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221: 275-277.
18. Ek B, Westermark B, Wasteson A, Heldin CH, (1982) Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature 295: 419-420.
19. Enge M, Bjarnegård M, Gerhardt H, Gustafsson E, Kalén M, Asker N, et al. (2002) Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J 21: 4307-4316.
20. Fischer A, Zalvide J, Faurobert E, Albiges-Rizo C, Tournier-Lasserve E, (2013) Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med 19: 302-308.
21. Gomez C, Luque A, Horenstein S, (1989) Microvasculopathy may precede idiopathic cerebral calcifications-case report. Angiology 40: 67-72.
22. Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisen J, (2011) A pericyte origin of spinal cord scar tissue. Science 333: 238-242.
23. Heldin CH, (2013) Targeting the PDGF signaling pathway in tumor treatment. Cell Commun Signal 11: 97.
24. Heldin CH, Westermark B, (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316.
25. Heldin CH, Westermark B, Wasteson A, (1979) Platelet-derived growth factor: purification and partial characterization. Proc Natl Acad Sci USA 76: 3722-3726.
26. Hellström M, Gerhardt H, Kalén M, Li X, Eriksson U, Wolburg H, et al. (2001) Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153: 543-553.
27. Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C, (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126: 3047-3055.
28. Heuchel R, Berg A, Tallquist M, Ahlén K, Reed RK, Rubin K, et al. (1999) Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling. Proc Natl Acad Sci USA 96: 11410-11415.
29. Hoch RV, Soriano P, (2003) Roles of PDGF in animal development. Development 130: 4769-4784.
30. Hsu S, Sears R, Lemos R, Quintáns B, Huang A, Spiteri E, et al. (2013) Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics 14: 11-22.
31. Ikeda M, Tanabe H, Mori T, Komori K, Nakagawa Y, Tanimukai S, et al. (1994) [A case of atypical presenile dementia]. Nō to Shinkei 46: 175-181.
32. Inden M, Iriyama M, Takagi M, Kaneko M, Hozumi I, (2013) Localization of type-III sodium-dependent phosphate transporter 2 in the mouse brain. Brain Res 1531: 75-83.
33. Ishii Y, Matsumoto Y, Watanabe R, Elmi M, Fujimori T, Nissen J, et al. (2008) Characterization of neuroprogenitor cells expressing the PDGF beta-receptor within the subventricular zone of postnatal mice. Mol Cell Neurosci 37: 507-518.
34. Ishii Y, Oya T, Zheng L, Gao Z, Kawaguchi M, Sabit H, et al. (2006) Mouse brains deficient in neuronal PDGF receptor-beta develop normally but are vulnerable to injury. J Neurochem 98: 588-600.
35. Iwayama T, Olson LE, (2013) Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities. Curr Rheumatol Rep 15: 304.
36. Jensen N, Schrøder H, Hejbøl E, Füchtbauer E-M, de Oliveira J, Pedersen L, (2013) Loss of function of Slc20a2 associated with familial idiopathic basal ganglia calcification in humans causes brain calcifications in mice. J Mol Neurosci 51: 994-999.
37. Johnsson A, Betsholtz C, Heldin CH, Westermark B, (1985) Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus. Nature 317: 438-440.
38. Kan LX, Peng CY, McGuire TL, Kessler JA, (2013) Glast-expressing progenitor cells contribute to heterotopic ossification. Bone 53: 194-203.
39. Keller A, Westenberger A, Sobrido M, García-Murias M, Domingo A, Sears R, et al. (2013) Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet 45: 1077-1082.
40. Kozik M, Kulczycki J, (1978) Laser-spectrographic analysis of the cation content in Fahr's syndrome. Archiv für Psychiatrie und Nervenkrankheiten 225: 135-142.
41. Lederer E, Miyamoto K, (2012) Clinical consequences of mutations in sodium phosphate cotransporters. Clin J Am Soc Nephrol 7: 1179-1187.
42. Levéen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C, (1994) Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8: 1875-1887.
43. Li X, Yang H-Y, Giachelli C, (2006) Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98: 905-912.
44. Lindahl P, Hellström M, Kalén M, Karlsson L, Pekny M, Pekna M, et al. (1998) Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 125: 3313-3322.
45. Lindahl P, Johansson BR, Levéen P, Betsholtz C, (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
46. Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellström M, et al. (2003) Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 17: 1835-1840.
47. Lu X-H, Fleming S, Meurers B, Ackerson L, Mortazavi F, Lo V, et al. (2009) Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J Neurosci 29: 1962-1976.
48. Maetzler W, Berg D, Funke C, Sandmann F, Stünitz H, Maetzler C, et al. (2010) Progressive secondary neurodegeneration and microcalcification co-occur in osteopontin-deficient mice. Am J Pathol 177: 829-839.
49. Maetzler W, Stünitz H, Bendfeldt K, Vollenweider F, Schwaller B, Nitsch C, (2009) Microcalcification after excitotoxicity is enhanced in transgenic mice expressing parvalbumin in all neurones, may commence in neuronal mitochondria and undergoes structural modifications over time. Neuropathol Appl Neurobiol 35: 165-177.
50. Kbox drawings light down and leftroǧlu Y, Çallbox drawings light down and left C, Karabulut N, Öncel C, (2010) Intracranial calcifications on CT. Diagn Interv Radiol 16: 263-269.
51. Manyam B, (2005) What is and what is not "Fahr's disease". Parkinsonism Relat Disord 11: 73-80.
52. Martignetti JA, Tian LF, Li D, Ramirez MCM, Camacho-Vanegas O, Camacho SC, et al. (2013) Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet 92: 1001-1007.
53. Medici D, Shore E, Lounev V, Kaplan F, Kalluri R, Olsen B, (2010) Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16: 1400-1406.
54. Miklossy J, Mackenzie I, Dorovini-Zis K, Calne D, Wszolek Z, Klegeris A, et al. (2005) Severe vascular disturbance in a case of familial brain calcinosis. Acta Neuropathol 109: 643-653.
55. New SEP, Goettsch C, Aikawa M, Marchini JF, Shibasaki M, Yabusaki K, et al. (2013) Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res 113: 72-77.
56. Nicolas G, Jacquin A, Thauvin-Robinet C, Rovelet-Lecrux A, Rouaud O, Pottier C, et al. (2014) A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia. Eur J Hum Genet [Epub ahead of print; doi: 10.1038/ejhg.2014.9.]
57. Nicolas G, Pottier C, Charbonnier C, Guyant-Maréchal L, Le Ber I, Pariente J, et al. (2013) Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain 136 (Pt 11): 3395-3407.
58. Nicolas G, Pottier C, Maltête D, Coutant S, Rovelet-Lecrux A, Legallic S, et al. (2013) Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology 80: 181-187.
59. Nicolas G, Rovelet-Lecrux A, Pottier C, Martinaud O, Wallon D, Vernier L, et al. (2014) PDGFB partial deletion: a new, rare mechanism causing brain calcification with leukoencephalopathy. J Mol Neurosci 53: 171-175.
60. Nisancioglu MH, Betsholtz C, Genové G, (2010) The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade. Cancer Res 70: 5109-5115.
61. Nomoto N, Sugimoto H, Iguchi H, Kurihara T, Wakata N, (2002) [A case of Fahr's disease presenting "diffuse neurofibrillary tangles with calcification"]. Rinshō Shinkeigaku 42: 745-749.
62. Norman R, Urich H, (1960) The influence of a vascular factor on the distribution of symmetrical cerebral calcifications. J Neurol Neurosurg Psychiatry 23: 142-147.
63. Nystrom HC, Lindblom P, Wickman A, Andersson I, Norlin J, Faldt J, et al. (2006) Platelet-derived growth factor B retention is essential for development of normal structure and function of conduit vessels and capillaries. Cardiovasc Res 71: 557-565.
64. O'Driscoll M, Daly S, Urquhart J, Black G, Pilz D, Brockmann K, et al. (2010) Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria. Am J Hum Genet 87: 354-364.
65. Olson LE, Soriano P, (2011) PDGFRβ signaling regulates mural cell plasticity and inhibits fat development. Dev Cell 20: 815-826.
66. Paschali A, Lakiotis V, Messinis L, Markaki E, Constantoyannis C, Ellul J, et al. (2009) Dopamine transporter SPECT/CT and perfusion brain SPECT imaging in idiopathic basal ganglia calcinosis. Clin Nucl Med 34: 421-423.
67. Phuong THN, Nakamura T, Hori E, Urakawa S, Uwano T, Zhao JJ, et al. (2011) Cognitive and socio-emotional deficits in platelet-derived growth factor receptor-beta gene knockout mice. PLoS ONE 6: e18004.
68. Raines SM, Richards OC, Schneider LR, Schueler KL, Rabaglia ME, Oler AT, et al. (2011) Loss of PDGF-B activity increases hepatic vascular permeability and enhances insulin sensitivity. Am J Physiol Endocrinol Metab 301: E517-E526.
69. Saito T, Nakamura M, Shimizu T, Oda K, Ishiwata K, Ishii K, et al. (2010) Neuroradiologic evidence of pre-synaptic and post-synaptic nigrostriatal dopaminergic dysfunction in idiopathic basal ganglia calcification: a case report. J Neuroimaging 20: 189-191.
70. Saitou M, Furuse M, Sasaki H, Schulzke J, Fromm M, Takano H, et al. (2000) Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11: 4131-4142.
71. Salisbury E, Rodenberg E, Sonnet C, Hipp J, Gannon F, Vadakkan T, et al. (2011) Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem 112: 2748-2758.
72. Schor A, Allen T, Canfield A, Sloan P, Schor S, (1990) Pericytes derived from the retinal microvasculature undergo calcification in vitro. J Cell Sci 97 (Pt 3): 449-461.
73. Shen J, Ishii Y, Xu GH, Dang TC, Hamashima T, Matsushima T, et al. (2012) PDGFR-beta as a positive regulator of tissue repair in a mouse model of focal cerebral ischemia. J Cereb Blood Flow Metab 32: 353-367.
74. Shibayama H, Kobayashi H, Iwase S, Nakagawa M, Marui Y, Kayukawa Y, et al. (1986) Unusual cases of presenile dementia with Fahr's syndrome. Jpn J Psychiatry Neurol 40: 85-100.
75. Shore E, Xu M, Feldman G, Fenstermacher D, Cho T-J, Choi I, et al. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38: 525-527.
76. Shoyama M, Shouyama M, Kitabata Y, Kaku T, Shinosaki K, (2005) Evaluation of regional cerebral blood flow in Fahr disease with schizophrenia-like psychosis: a case report. AJNR Am J Neuroradiol 26: 2527-2529.
77. Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, et al. (1997) Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15: 95-98.
78. Sjöblom T, Shimizu A, O'Brien KP, Pietras K, Dal Cin P, Buchdunger E, et al. (2001) Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res 61: 5778-5783.
79. Smeyers-Verbeke J, Michotte Y, Pelsmaeckers J, Lowenthal A, Massart D, Dekegel D, et al. (1975) The chemical composition of idiopathic nonarteriosclerotic cerebral calcifications. Neurology 25: 48-57.
80. Smits A, Kato M, Westermark B, Nistér M, Heldin CH, Funa K, (1991) Neurotrophic activity of platelet-derived growth factor (PDGF): rat neuronal cells possess functional PDGF beta-type receptors and respond to PDGF. Proc Natl Acad Sci USA 88: 8159-8163.
81. Sobrido MJ, Coppola G, Oliveira J, Hopfer S, Geschwind DH, (1993-2013) Primary familial brain calcification. In: GeneReviews(R)., RA Pagon, MP Adam, TD Bird, CR Dolan, CT Fong, RJH Smith, (eds). GeneReviews® [Internet]: Seattle (WA).
82. Soderblom C, Luo XT, Blumenthal E, Bray E, Lyapichev K, Ramos J, et al. (2013) Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury. J Neurosci 33: 13882-13887.
83. Soriano P, (1994) Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 8: 1888-1896.
84. Stark K, Eckart A, Haidari S, Tirniceriu A, Lorenz M, von Bruehl ML, et al. (2013) NG2(+) pericytes support interstitial migration and effector function of myeloid leukocytes during sterile inflammation. Eur J Clin Invest 43: 3.
85. Stark K, Eckart A, Haidari S, Tirniceriu A, Lorenz M, von Bruhl ML, et al. (2013) Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and "instruct" them with pattern-recognition and motility programs. Nat Immunol 14: 41-51.
86. Tallquist MD, French WJ, Soriano P, (2003) Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development. PLoS Biol 1: E52.
87. Uygur G, Liu Y, Hellman R, Tikofsky R, Collier B, (1995) Evaluation of regional cerebral blood flow in massive intracerebral calcifications. J Nucl Med 36: 610-612.
88. Vígh B, Szél A, Debreceni K, Fejér Z, Manzano e Silva M, Vígh-Teichmann I, (1998) Comparative histology of pineal calcification. Histol Histopathol 13: 851-870.
89. Villa-Bellosta R, Levi M, Sorribas V, (2009) Vascular smooth muscle cell calcification and SLC20 inorganic phosphate transporters: effects of PDGF, TNF-alpha, and Pi. Pflügers Arch 458: 1151-1161.
90. Wang C, Li Y, Shi L, Ren J, Patti M, Wang T, et al. (2012) Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet 44: 254-256.
91. Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, et al. (1983) Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304: 35-39.
92. Xu G, Shen J, Ishii Y, Fukuchi M, Dang TC, Zheng Y, et al. (2013) Functional analysis of platelet-derived growth factor receptor-beta in neural stem/progenitor cells. Neuroscience 238: 195-208.
93. Yamada M, Tanaka M, Takagi M, Kobayashi S, Taguchi Y, Takashima S, et al. (2014) Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan. Neurology 82: 705-712.
94. Yao Y, Jumabay M, Ly A, Radparvar M, Cubberly M, Boström K, (2013) A role for the endothelium in vascular calcification. Circ Res 113: 495-504.
95. Zhang Y, Guo X, Wu A, (2013) Association between a novel mutation in SLC20A2 and familial idiopathic basal ganglia calcification. PLoS ONE 8: e57060.